Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant

Haematologica

Volumn 99, Issue 5, 2014, Pages

  Morton, Lindsay M ^a   Gibson, Todd M ^a   Clarke, Christina A ^b   Lynch, Charles F ^c   Weisenburger, Dennis D ^d   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

HBV; HCV; NHL after solid organ transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; CELL PROLIFERATION; CHILD; DEMOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SEROLOGY; CHRONIC HEPATITIS C; COMPLICATION; GRAFT RECIPIENT; LYMPHOMA, NON-HODGKIN; RISK; UNITED STATES;

HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LYMPHOMA, NON-HODGKIN; ORGAN TRANSPLANTATION; RISK; TRANSPLANT RECIPIENTS; UNITED STATES;

EID: 84899740660     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.101600     Document Type: Letter

References (15)

1. Zemel R, Issachar A, Tur-Kaspa R. The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis. 2011; 15(2): 261-79, vii-x.
2. Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol. 2010; 11(9): 827-34.
3. Nath A, Agarwal R, Malhotra P, Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010; 40(9): 633-41.
4. Becker N, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadie M, et al. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol. 2012; 138(12): 1993-2001.
5. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013; 59(1): 169-77.
6. Conca P, Tarantino G. Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. World J Gastroenterol. 2009; 15(19): 2305-8.
7. Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, lowgrade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol. 2005; 23(3): 468-73.
8. Pontisso P, Vidalino L, Quarta S, Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev. 2008; 8(1): 13-7.
9. Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, et al. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood. 2007; 110(13): 4599-605.
10. Izadi M, Taheri S. Hepatitis B virus infection has no significant role on lymphoproliferative disorders post liver transplantation: PTLD. int survey. Ann Hepatol. 2011; 10(3): 315-20.
11. Khedmat H, Taheri S. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD. Int survey. Exp Clin Transplant. 2012; 10(2): 141-7.
12. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, et al. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013; 109(1): 280-8.
13. Zhang A, Zhang M, Shen Y, Wang W, Zheng S. Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation. Clin Transplant. 2009; 23(5): 756-60.
14. Waters L, Stebbing J, Mandalia S, Young AM, Nelson M, Gazzard B, et al. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study. Int J Cancer. 2005; 116(1): 161-3.
15. Franceschi S, Polesel J, Rickenbach M, Dal Maso L, Probst-Hensch NM, Fux C, et al. Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. Br J Cancer. 2006; 95(11): 1598-602.